Prosecution Insights
Last updated: April 19, 2026

Examiner: KWON, YONG SOK

Tech Center 1600 • Art Units: 1600 1613 1614 1625

This examiner grants 22% of resolved cases

Performance Statistics

22.0%
Allow Rate
-38.0% vs TC avg
68
Total Applications
+46.6%
Interview Lift
1739
Avg Prosecution Days
Based on 59 resolved cases, 2023–2026

Rejection Statute Breakdown

2.0%
§101 Eligibility
13.2%
§102 Novelty
40.5%
§103 Obviousness
23.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17640253 NOVEL COMPOSITIONS Final Rejection DSM IP ASSETS B.V.
17642595 PREMIX AND COMPOSITION AND METHODS OF PREPARING THE SAME Non-Final OA Conopco, Inc., d/b/a UNILEVER
18617328 HYPOCHLOROUS ACID-BASED DRY EYE FORMULATIONS Non-Final OA OCuSOFT, Inc.
17920857 ORAL FILM OF HIV DRUGS Final Rejection LAURUS LABS LIMITED
18014157 COMPOUND AS BRAIN-PERMEABLE BTK OR HER2 INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF Non-Final OA SHENZHEN HYPERWAY PHARMACEUTICALS CO., LTD.
18021523 SPERMIDINE AND USES THEREOF Final Rejection TLL THE LONGEVITY LABS GMBH

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month